10.1016/j.exger.2020.111212 Exp
We excluded patients with cirrhotic liver, history of gall bladder, biliary disorders, pancreatic diseases, interrupted use of GLP-1RAs throughout the study period, and patients used other drugs with potential effects on the motility of biliary tracts such as cholecystokinin, motilin hormone, cholinomimetic agents like prostigmine, erythromycin, cisapride, cholystyramine, intravenous aminoacids, cholinergic agents like atropine, somatostatin, and progesterone, trimebutine, loperamide and ondansetron
What lessons did you take away from those choices
It is also not excluded that the same supplementation protocol without training program may induce different response in SPARC and decorin levels
When to Contact Your Provider and Explore Alternative Semaglutide Options Nausea that persists beyond the third or fourth week of semaglutide therapy, or that becomes severe enough to prevent you from eating adequately or staying hydrated, warrants a conversation with your healthcare provider